AzTrials
AzTrials

Subjective TinnitusPhase 2NCT01268449

Evaluation of Low Dose Laser in Treatment of Tinnitus

A Phase 2 study testing Low dose laser in people with Subjective Tinnitus, run by Islamic Azad University of Mashhad.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine wether low dose laser is effective on idiopathic subjective tinnitus. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Subjective Tinnitus
What is being tested?
Low dose laser
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
66 participants
Where
No sites listed yet
Study dates
Mar 2008to Sep 2010
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults older than 18 years old
  • Idiopathic, subjective, unilateral tinnitus with at least 2 month duration

Who cannot join

  • Patients with chronic otitis media
  • Patients with tympan perforation with any underlying cause
  • Patients with external otitis
  • Patients with tinnitus related to a retrocochlear lesion or other known lesions of the ear

About this study

Official title: Phase 1 Evaluation of Low Dose Laser in Treatment of Tinnitus

The purpose of this study is to determine wether low dose laser is effective on idiopathic subjective tinnitus.

Being tested
Low dose laser, Placebo
Keywords
Tinnitus, Low power laser
Medical subject headings
Tinnitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Low dose laserRadiation

    5mv laser with a wavelength of 650nm

  • PlaceboRadiation

    The act of radiating laser to the ear is done while the set is off.

Study groups in NCT01268449
Study groupRoleWhat they receive
Laser groupActive comparatorNot described
Receives: Radiation: Low dose laser
Placebo groupPlacebo comparatorRandomly,half of the patients receive placebo.
Receives: Radiation: Placebo

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2010 (estimated)
  2. Study startMar 2008
  3. Primary completionAug 2010
  4. Study completionSep 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
66 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01268449
Sponsor's protocol ID
Laser-tinnitus-202
Status last verified
Aug 2010
First submitted
29 Dec 2010
Last updated
30 Dec 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Low dose laser in people with Subjective Tinnitus, run by Islamic Azad University of Mashhad.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Dec 2010. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Dec 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in